Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile.
  Pharmaceutical Technology Europe E-Alert
 
15 April 2011

IN THIS ISSUE
J&J corruption
FDA guidance
Merck and Sun
PTE April

 
J&J settles over corrupt practices
Johnson and Johnson (J&J) has agreed to pay more than $77 million after being charged for violations of the US Foreign Corrupt Practices Act (FCPA), which include bribing public doctors in several European countries and paying kickbacks to illegally obtain business in Iraq. More...
 
FDA publishes guidance for preventing cross-contamination
The FDA has published guidance and recommendations for preventing the cross-contamination of finished pharmaceuticals and APIs with non-penicillin beta-lactam antibiotics. More...
 
Merck forms joint venture with Sun Pharmaceutical
Merck has teamed up with India-based Sun Pharmaceutical Industries to develop, manufacture and commercialise new combinations and formulations of branded generic drugs in emerging markets. More...
 
Have you seen...?
The April issue of Pharmaceutical Technology Europe? The latest issue includes articles on particle characterisation, FDA Warning Letters and a special feature on tabletting. More...
 
Record number of cancer therapies in development
Nearly 900 therapies for the treatment, diagnosis, or prevention of cancer are currently in development, according to a report released by the Pharmaceutical Research and Manufacturers of America (PhRMA) — more than double the number of therapies that were in development six years ago. More...
 
Join our community on LinkedIn
Want to discuss any of this week's news stories or any other hot topics in the industry? Then why not join our group on LinkedIn? More...

Latest blog posts
Shared value in action
Biotech leader provides testimony at congressional hearing
EMA issues packaging and labelling recommendations
More blog posts

Latest columns
Reforming the approach to pharmacovigilance in Europe
A hard look at third-party external supply networks
Pitfalls in statistics
More articles

Upcoming events
Pharmaceutical Compliance Forum 5th Intl Pharmaceutical Compliance Congress (2–5 May | Turkey)
Respiratory Drug Delivery Europe 2011 (3–6 May | Germany)
ExcipientFest (10–11 May | USA)
More events

Product Profiles
Avantor

Improve the Performance and Lower the Costs of ODT Drug Applications
J.T.Baker® PanExcea™ MC200G performance excipient from Avantor™ Performance Materials (formerly Mallinckrodt Baker) is an orally disintegrating tablet (ODT). Read more...

 
Sepha

Global packaging machinery expert, Sepha Ltd, has developed the world's first tool-less, vision-based leak detection machine for blister-packs.
Read more...


Live Webcast
Evonik

May 3rd 2011, 11:00am – 12:00pm EDT
Strategies in Bioavailability Enhancement of Poorly Permeable Small and Large Molecular Entities (BCS III & IV) Learn the challenges of formulating poorly permeable drugs and the importance for therapeutic applications and understand strategies to enhance bioavailability of such drugs . Read more...


Event Profile
 


10th Annual Biological Production Forum 2011
20-22 June 2011
Sheraton Frankfurt Airport Hotel and Conference Center
Frankfurt, Germany
10th Annual Biological Production Forum 2011 is well established as the event for both upstream and downstream processing for biological manufacturing, production and cGMP specialists. Read more...



Survey
Do you think that quality by design has become or is becoming an important element in the CMC requirements between a contract manufacturing organization and sponsor company?
Yes 84%
 
No 16%

This week we would like to know...

What is driving new developments in immediate-release drug delivery?

Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.

 
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, please contact us by emailing magazines@superfill.com or by mail
at Advanstar Communications Inc., Bridgegate Pavilion, 4A Chester Business Park, Wrexham Road, Chester, CH4 9QH, UK.